Study: Test accurate in spotting early-stage Alzheimer's

03/16/2009 | Yahoo!

U.S. scientists found that a new test was 87% accurate in pinpointing whom among patients with early memory problems would likely develop Alzheimer's disease. The test works by quantifying the concentration of amyloid beta 42 polypeptide and the amount of the tau protein in spinal fluid. The technique will enable scientists to improve the clinical trials of Alzheimer's drugs, a researcher said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX